Cryptotanshinone was regarded as the STAT3 and STAT5 regulator for ischemic stroke (Zhu et al., 2021) and chronic myelocytic leukemia (Dong et al., 2018). Here, STAT3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.